Ultragenyx Pharmaceutical Inc. - Aug 10, 2021 Form 4 Insider Report for Arcturus Therapeutics Holdings Inc. (ARCT)

Role: Director
Signature: /s/ Mardi C. Dier, EVP and Chief Financial Officer
Stock symbol: ARCT
Transactions as of: Aug 10, 2021
Transactions value $: -$43,631,250
Form type: 4
Date filed: 8/12/2021, 05:11 PM

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ARCT	Common Stock	Sale	-$40.2M	-725K	-32.95%	$55.44	1.48M	Aug 10, 2021	Direct	F1
transaction	ARCT	Common Stock	Sale	-$3.44M	-75K	-5.08%	$45.83	1.4M	Aug 11, 2021	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $64.75 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F2	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $47.22 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Content

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $64.75 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $47.22 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.